Usefulness of contrast-enhanced mammography in breast cancer diagnosis strategy - INAHTA Brief
Health technology assessment -
Posted on
Nov 22 2021
- Updated on
Nov 22 2021
HAS has assessed contrast-enhanced mammography (CEM) in the breast cancer diagnosis strategy to issue an opinion on listing the procedure in the joint classification of medical procedures. The aim of the assessment was to i) compare the diagnostic performances of contrast-enhanced mammography to breast MRI in certain indications, ii) to evaluate safety in relation to exposure to ionising radiation and to reactions secondary to iodinated contrast agent injection, iii) to evaluate the impact of CEM on the therapeutic strategy and iv) to assess organisational impacts of CEM
Documents
English version
Contact Us
Évaluation des actes professionnels